Get A Free Legal Consultation
- We fight to maximize your results
- No out-of-pocket costs
- Over $10.6 billion recovered for families
Michael J. Angelides is a partner at Simmons Hanly Conroy and focuses his practice on mass torts and asbestos litigation. He previously served as the firm’s managing partner for 15 years and has been with the firm since 2001. Mike’s litigation track record includes growing the firm’s reputation as a national leader in mass torts and asbestos litigation, representing clients and cancer victims against some of the largest companies in the nation.
Mike has also been instrumental in the growth of the firm’s pharmaceutical injury and complex litigation practices. Firm attorneys have been appointed to leadership in numerous multidistrict litigations, including Co-Lead of Prescription Opiates. Other examples of litigation where Simmons Hanly Conroy attorneys have been appointed to leadership include Vioxx, Toyota Unintended Acceleration, BP Deepwater Horizon Oil Spill, DePuy Pinnacle, and the Volkswagen Emission Scandal. Under Mike’s direction, the firm has recovered over 7 billion dollars on behalf of its clients.
Mike does not stop fighting for the firm’s clients when they leave the courtroom. He is a passionate advocate for worker and consumer rights. “I’ve learned that many large companies will stop at nothing to cover up their wrongdoings and avoid taking responsibility for their actions,” Mike said. Under his direction Simmons Hanly Conroy has donated over $10 million dollars through the firm’s charitable foundations that are dedicated to working with mesothelioma medical experts, researchers, hospitals, and universities with the hope of hastening a cure. Non-profit corporations who have received donations include the Mesothelioma Applied Research Foundation, and the Asbestos Disease Awareness Organization.
“It is our hope that someday we won’t have any more clients diagnosed with mesothelioma or asbestos-related diseases because doctors will have found a cure for these rare and preventable diseases,” he said. “Until that day arrives, we will continue to provide our clients with compassionate legal care.”
In re: Syngenta AG MIR162 Corn Litigation, MDL 259 (D. Kan.)
In re: National Prescription Opiate Litigation, MDL 2804 (N.D. Ohio 2018)
In re: DePuy Orthopaedics, Inc. Pinnacle Hip Implant Products Liability Litigation, MDL Docket No. 2244 (N.D. Tex.)
In re: Volkswagen “Clean Diesel” Marketing, Sales Practices, And Products Liability Litigation, MDL No. 2672
In re: Toyota Motor Corp. Unintended Acceleration Marketing, Sales Practices, and Product Liability Litigation, MDL 2151 (C.D. Cal.)
In re: Lipitor Products Liability Litigation, MDL 2502 (D.S.C.)
Board Member Insys Liquidation Trust, in re: INSYS THERAPEUTICS, INC., et al., United States Bankruptcy Court for the District of Delaware
St. Louis Regional Crime Commission
In 2010, Mike was identified as an upcoming “40 under 40” lawyer by The St. Louis Business Journal.
From 2013-2023, Mike was named by The Best Lawyers in America as a leader in Personal Injury—Plaintiffs, as well as being recognized as a top lawyer for Class Actions—Plaintiffs, from 2021-2023.
In 2018, Mike was also recognized as a Missouri law firm leader by Missouri Lawyers Weekly.
2022 Largest Plaintiff Settlements and Verdicts, Missouri Lawyers Weekly.
Martindale Hubble AV rated
After graduating with honors from Kenyon College in Ohio, Mike enrolled in St. Louis University’s Law School. After law school, he worked for Judge Paul J. Simon on the Missouri Court of Appeals, Eastern District of Missouri. It was here he realized he wanted to be the kind of lawyer who made a difference in the lives of individuals and families. That meant becoming a plaintiff’s attorney.
“I always liked representing the underdog,” Mike said. “This kind of work, fighting against people who had wronged someone else in some way, seemed the most satisfying and enjoyable.”
In 2001, Mike left his private practice to become the firm’s seventh asbestos attorney, and in 2009, he became a member of the firm’s leadership committee.